Cindy T. McEvoy 1 and Eliot R. Spindel 2
doi : 10.1164/rccm.202201-0108ED
Volume 205, Issue 8 | April 15 2022
Dave Singh 1 and Chris Brightling 2
John C. Gomez 1,2 and Claire M. Doerschuk 1,2
Richard M. Schwartzstein 1 and Margaret L. Campbell 2
Joshua M. Diamond
Giacomo Sgalla 1, Marlies S. Wijsenbeek 2, and Luca Richeldi 1
Danny J. Eckert 1 and Scott A. Sands 2
Darryl Abrams 1,2, Cara Agerstrand 1,2, Jeremy R. Beitler 1,2, Christian Karagiannidis 3, Purnema Madahar 1,2, Natalie H. Yip 1,2, Antonio Pesenti 4, Arthur S. Slutsky 5,6,7*, Laurent Brochard 5,6,7*, and Daniel Brodie 1,2*
doi : 10.1164/rccm.202110-2252CP
Lung-protective ventilation strategies are the current standard of care for patients with acute respiratory distress syndrome in an effort to provide adequate ventilatory requirements while minimizing ventilator-induced lung injury.
Sadia Haider 1, Raquel Granell 2, John Curtin 3, Sara Fontanella 1, Alex Cucco 1, Stephen Turner 4,5, Angela Simpson 3, Graham Roberts 6,7,8, Clare S. Murray 3, John W. Holloway 6,7, Graham Devereux 9, Paul Cullinan 1, Syed Hasan Arshad 7,8,10, and Adnan Custovic 1
doi : 10.1164/rccm.202108-1821OC
Rationale: Longitudinal modeling of current wheezing identified similar phenotypes, but their characteristics often differ between studies.
Amelia Shoemark 1,2, Michal Shteinberg 3, Anthony De Soyza 4,5, Charles S. Haworth 6,7, Hollian Richardson 1, Yonghua Gao 8, Lidia Perea 9, Alison J. Dicker 1, Pieter C. Goeminne 10, Erin Cant 1, Eva Polverino 11,12, Josje Altenburg 13, Holly R. Keir 1, Michael R. Loebinger 2, Francesco Blasi 14,15, Tobias Welte 16, Oriol Sibila 9, Stefano Aliberti 17,18, and James D. Chalmers 1
doi : 10.1164/rccm.202108-1889OC
Rationale: Bronchiectasis is classically considered a neutrophilic disorder, but eosinophilic subtypes have recently been described.
Katharine M. Lodge 1,2, Arlette Vassallo 1, Bin Liu 1, Merete Long 3, Zhen Tong 1, Paul R. Newby 4, Danya Agha-Jaffar 2, Koralia Paschalaki 2, Clara E. Green 4, Kylie B. R. Belchamber 4, Victoria C. Ridger 3, Robert A. Stockley 5, Elizabeth Sapey 4,5, Charlotte Summers 1, Andrew S. Cowburn 2, Edwin R. Chilvers 1,2, Wei Li 1*, and Alison M. Condliffe 1,3*
doi : 10.1164/rccm.202006-2467OC
Rationale: Patients with chronic obstructive pulmonary disease (COPD) experience excess cardiovascular morbidity and mortality, and exacerbations further increase the risk of such events. COPD is associated with persistent blood and airway neutrophilia and systemic and tissue hypoxia. Hypoxia augments neutrophil elastase release, enhancing capacity for tissue injury.
Alexandre Demoule 1,2,3, David Hajage 4,5, Jonathan Messika 6, Samir Jaber 7, Hassimiou Diallo 4,5, Maxime Coutrot 3,8,9, Achille Kouatchet 10, Elie Azoulay 11, Muriel Fartoukh 3,12,13,14, Sami Hraiech 15,16, Pascal Beuret 17, Michael Darmon 11, Maxens Decavèle 1,2,3, Jean-Damien Ricard 18, Gerald Chanques 7, Alain Mercat 10, Matthieu Schmidt 3,8,9, and Thomas Similowski 1,19; for the REVA Network (Research Network in Mechanical Ventilation)
doi : 10.1164/rccm.202108-1857OC
Rationale: Dyspnea is a traumatic experience. Only limited information is available on dyspnea in intubated critically ill patients.
Farzad Moazed 1,2,3, Carolyn Hendrickson 1, Alejandra Jauregui 1, Jeffrey Gotts 1,2, Amanda Conroy 4, Kevin Delucchi 2,5, Hanjing Zhuo 6, Mikhaela Arambulo 7, Kathryn Vessel 1, Serena Ke 1, Thomas Deiss 1, Amy Ni 1, Aleksandra Leligdowicz 1, Jason Abbott 1, Mitchell J. Cohen 8, Pratik Sinha 1, Antonio Gomez 1, Kirsten Kangelaris 1, Lucy Kornblith 4, Michael Matthay 1,6,7, Neal Benowitz 1,2, Kathleen Liu 1, and Carolyn S. Calfee 1,2,6,7
doi : 10.1164/rccm.202105-1098OC Â
Rationale: Cigarette smoke exposure is associated with an increased risk of developing acute respiratory distress syndrome (ARDS) in trauma, transfusion, and nonpulmonary sepsis. It is unknown whether this relationship exists in the general sepsis population. Furthermore, it is unknown if patients with ARDS have differences in underlying biology based on smoking status.
Fasihul A. Khan 1,2, Iain Stewart 1,2,3, Samuel Moss 1,2,3, Laura Fabbri 1,2,3, Karen A. Robinson 4, Simon R. Johnson 1,2, and R. Gisli Jenkins 1,2,3
doi : 10.1164/rccm.202109-2091OC
Rationale: Novel therapies for idiopathic pulmonary fibrosis (IPF) are in development, but there remains uncertainty about the optimal trial endpoint. An earlier endpoint would enable assessment of a greater number of therapies in adaptive trial designs.
Gino S. Panza 1,2, Shipra Puri 1,2, Ho-Sheng Lin 1,3, M. Safwan Badr 1,2,4, and Jason H. Mateika 1,2,4
doi : 10.1164/rccm.202108-1808OC
Rationale: Daily exposure to mild intermittent hypoxia (MIH) may elicit beneficial cardiovascular outcomes.
Rong Ma 1*, Gui-Liang Wang 1*, Jian-Bin Liu 1, Li Cai 2‡, Peng Liu 1‡, and Xian-Zheng Tan 1‡
Takahiro Shimizu , Satoshi Watanabe , Akari Murata , and Kazuo Kasahara
Bruno Evrard 1,2*, Marine Goudelin 1,2, Julien Vaidie 1, Anne-Laure Fedou 1, and Philippe Vignon 1,2
Lucie Sauerhering 1,2*, Irina Kuznetsova 3*, Alexandra Kupke 1, Lars Meier 1, Sandro Halwe 1, Cornelius Rohde 1, Jörg Schmidt 1, Rory E. Morty 3,4, Olga Danov 4,5, Armin Braun 4,5, István Vadász 3,4,6, Stephan Becker 1,2‡, and Susanne Herold 2,3,4,6‡§
Yewon Chung 1,2,3*, Frances L. Garden 1,3, Guy B. Marks 1,2,3, and Hima Vedam 1,2,3
Kirsten A. Kalverda 1*, Margherita Vaselli 2, Lizzy Wijmans 1, Daniel M. de Bruin 1, René E. Jonkers 1, Venerino Poletti 3,4, Johannes de Boer 2, Jouke T. Annema 1, and Peter I. Bonta 1
Sreyankar Nandy 1,2*, Rebecca A. Raphaely 1,2*, Ashok Muniappan 1,2, Angela Shih 1,2, Benjamin W. Roop 1, Amita Sharma 1,2, Colleen M. Keyes 1,2, Thomas V. Colby 3, Hugh G. Auchincloss 1,2, Henning A. Gaissert 1,2, Michael Lanuti 1,2, Christopher R. Morse 1,2, Harald C. Ott 1,2, John C. Wain 1,2,4, Cameron D. Wright 1,2, Maria L. Garcia-Moliner 5, Maxwell L. Smith 3, Paul A. VanderLaan 2,6, Sarita R. Berigei 1, Mari Mino-Kenudson 1,2, Nora K. Horick 1,2, Lloyd L. Liang 1, Diane L. Davies 1, Margit V. Szabari 1,2, Peter Caravan 2,7,8, Benjamin D. Medoff 1,2, Andrew M. Tager 1,2†, Melissa J. Suter 1,2, and Lida P. Hariri 1,2‡ ... Show less
Eugenio Baraldi 1 and Giorgio Piacentini 2*
Liesbeth Duijts 1, Louise J. Fleming 2, Leonard B. Bacharier 3, Paulo M. Pitrez 4, and Helen K. Reddel 5,6*; on behalf of all the authors
Thomas DeCato and Marianna Sockrider
doi : 10.1164/rccm.2058P15
Do you want to add Medilib to your home screen?